Characteristics of Patients With APL in the Present Study
. | Newly Diagnosed APL . | Relapsed APL . |
---|---|---|
Evaluated cases | 11 | 47 |
Sex (male/female) | 3/8 | 29/18 |
Median age (range, years) | 41 (24 to 60) | 38 (7 to 55) |
Median WBC (range, ×109/L) | 2.2 (1.1 to 65.0) | 3.4 (0.6 to 56.0) |
<2 | 4 | 14 |
2 to 10 | 4 | 24 |
10 to 20 | 1 | 3 |
>20 | 2 | 6 |
Median RBC (range, ×1012/L) | 2.33 (1.03 to 2.96) | 3.65 (1.78 to 5.31) |
Median hemoglobin (range, g/L) | 70 (51 to 97) | 109 (56 to 180) |
Median platelet (range, ×109/L) | 20 (10 to 50) | 38 (4 to 236) |
Median percentage of blasts and promyelocytes in BM (range) | 87.5 (38.0 to 95.5) | 66.0 (12.5 to 95.0) |
. | Newly Diagnosed APL . | Relapsed APL . |
---|---|---|
Evaluated cases | 11 | 47 |
Sex (male/female) | 3/8 | 29/18 |
Median age (range, years) | 41 (24 to 60) | 38 (7 to 55) |
Median WBC (range, ×109/L) | 2.2 (1.1 to 65.0) | 3.4 (0.6 to 56.0) |
<2 | 4 | 14 |
2 to 10 | 4 | 24 |
10 to 20 | 1 | 3 |
>20 | 2 | 6 |
Median RBC (range, ×1012/L) | 2.33 (1.03 to 2.96) | 3.65 (1.78 to 5.31) |
Median hemoglobin (range, g/L) | 70 (51 to 97) | 109 (56 to 180) |
Median platelet (range, ×109/L) | 20 (10 to 50) | 38 (4 to 236) |
Median percentage of blasts and promyelocytes in BM (range) | 87.5 (38.0 to 95.5) | 66.0 (12.5 to 95.0) |